Pharmaron Beijing Co Ltd (3759.HK)
Company Info
Highlights
HK$41.23B
HK$1.07
11.98
HK$12.70B
HK$4.37B
HK$7.98 - HK$24.85
HK$20.24
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Pharmaron Beijing Co Ltd (3759.HK) returned -3.26% year-to-date (YTD) and 25.43% over the past 12 months.
3759.HK
-3.26%
6.07%
-9.43%
25.43%
-12.36%
N/A
^GSPC (Benchmark)
0.19%
9.00%
-1.55%
12.31%
15.59%
10.78%
Monthly Returns
The table below presents the monthly returns of 3759.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.00% | 9.08% | 4.16% | -15.73% | 1.04% | -3.26% | |||||||
| 2024 | -36.03% | 3.95% | -8.94% | 1.36% | 1.24% | -11.94% | 13.85% | -7.07% | 67.79% | 0.27% | -11.30% | 5.70% | -8.70% |
| 2023 | 6.00% | -23.52% | -24.94% | 2.73% | -14.62% | -16.26% | 27.91% | -9.63% | 1.86% | 0.11% | 1.29% | -16.30% | -55.34% |
| 2022 | -17.91% | -4.41% | 1.11% | 4.66% | -5.26% | 25.49% | -18.59% | -18.45% | -26.85% | -30.80% | 68.18% | 21.96% | -31.94% |
| 2021 | 13.89% | -11.13% | 10.78% | 9.67% | 15.39% | 11.57% | -17.83% | 1.47% | 7.94% | -9.02% | -5.19% | -25.14% | -7.99% |
| 2020 | 14.48% | 6.43% | -4.81% | 22.10% | 2.11% | 27.52% | 5.19% | 22.40% | -6.41% | 16.08% | -15.91% | 39.21% | 201.93% |
| 2019 | -0.71% | 3.69% | 2.96% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 3759.HK is 70, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Pharmaron Beijing Co Ltd (3759.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Pharmaron Beijing Co Ltd provided a 1.61% dividend yield over the last twelve months, with an annual payout of HK$0.22 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Dividend | HK$0.22 | HK$0.22 | HK$0.33 | HK$0.35 | HK$0.16 | HK$0.07 |
Dividend yield | 1.61% | 1.56% | 2.08% | 0.98% | 0.30% | 0.12% |
Monthly Dividends
The table displays the monthly dividend distributions for Pharmaron Beijing Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.22 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.22 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.33 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.33 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.35 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.35 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.16 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.16 |
| 2020 | HK$0.07 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.07 |
Dividend Yield & Payout
Dividend Yield
Pharmaron Beijing Co Ltd has a dividend yield of 1.61%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Pharmaron Beijing Co Ltd has a payout ratio of 20.46%, which is below the market average. This means Pharmaron Beijing Co Ltd returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Pharmaron Beijing Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Pharmaron Beijing Co Ltd was 90.78%, occurring on Aug 23, 2024. The portfolio has not yet recovered.
The current Pharmaron Beijing Co Ltd drawdown is 84.44%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.78% | Jun 29, 2021 | 777 | Aug 23, 2024 | — | — | — |
| -37.47% | Jan 26, 2021 | 29 | Mar 9, 2021 | 48 | May 20, 2021 | 77 |
| -28.72% | Feb 18, 2020 | 25 | Mar 23, 2020 | 20 | Apr 22, 2020 | 45 |
| -23.25% | Nov 10, 2020 | 15 | Nov 30, 2020 | 15 | Dec 21, 2020 | 30 |
| -14.96% | Aug 31, 2020 | 9 | Sep 10, 2020 | 20 | Oct 12, 2020 | 29 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Pharmaron Beijing Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Pharmaron Beijing Co Ltd, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -19.4%.
Valuation
The Valuation section provides an overview of how Pharmaron Beijing Co Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 3759.HK, comparing it with other companies in the Biotechnology industry. Currently, 3759.HK has a P/E ratio of 12.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 3759.HK relative to other companies in the Biotechnology industry. Currently, 3759.HK has a P/S ratio of 3.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 3759.HK in comparison with other companies in the Biotechnology industry. Currently, 3759.HK has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |